Seattle Researchers Engineer HIV-Resistant T Cell
Ross Reynolds speaks with Dr. David Rawlings, director of the Center for Immunity and Immunotherapies at Seattle Children's Research Institute, about how his team pioneered a breakthrough gene-editing technique that could help patients with HIV, genetic blood diseases and certain cancers. Their study was published in the September issue of Science Translational Medicine.
